Calsada Crispina Insider Trades

Insider Trading History

Track insider trading activity for Calsada Crispina. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Regulus Therapeutics
Regulus Therapeutics RGLS
Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Jun 25, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$81.6k 10,000 shares
$8.16
$8.16
Regulus Therapeutics
Regulus Therapeutics RGLS
Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Jun 25, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$40.8k 5,000 shares
$8.16
$8.16
Regulus Therapeutics
Regulus Therapeutics RGLS
Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Jun 25, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$1.14M 140,228 shares
$8.16
$8.16
Regulus Therapeutics
Regulus Therapeutics RGLS
Chief Financial Officer
Holding Value $4.59M 562,500 shares
Last Trade
Jan 30, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$563k 562,500 shares
$1.00
$8.16
Regulus Therapeutics
Regulus Therapeutics RGLS
Chief Financial Officer
Holding Value $371k 45,478 shares
Last Trade
Jan 14, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$6.41k 5,088 shares
$1.26
$8.16
Regulus Therapeutics
Regulus Therapeutics RGLS
Chief Financial Officer
Holding Value $413k 50,566 shares
Last Trade
Jan 13, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$48.8k 38,716 shares
$1.26
$8.16
Regulus Therapeutics
Regulus Therapeutics RGLS
Chief Financial Officer
Holding Value $729k 89,282 shares
Last Trade
Jan 09, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$124k 83,500 shares
$1.49
$8.16
Regulus Therapeutics
Regulus Therapeutics RGLS
Chief Financial Officer
Holding Value $3.77M 462,000 shares
Last Trade
May 20, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$929k 462,000 shares
$2.01
$8.16
Regulus Therapeutics
Regulus Therapeutics RGLS
Chief Financial Officer
Holding Value $47.2k 5,782 shares
Last Trade
Jan 18, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$6.51k 5,468 shares
$1.19
$8.16
Regulus Therapeutics
Regulus Therapeutics RGLS
Chief Financial Officer
Holding Value $694k 85,000 shares
Last Trade
Jan 12, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$111k 85,000 shares
$1.30
$8.16
Regulus Therapeutics
Regulus Therapeutics RGLS
Chief Financial Officer
Holding Value $3.06M 375,000 shares
Last Trade
Aug 10, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$510k 375,000 shares
$1.36
$8.16
Regulus Therapeutics
Regulus Therapeutics RGLS
Chief Financial Officer
Holding Value $367k 45,000 shares
Last Trade
Jan 11, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$66.6k 45,000 shares
$1.48
$8.16
Regulus Therapeutics
Regulus Therapeutics RGLS
Chief Financial Officer
Holding Value $408k 50,000 shares
Last Trade
May 10, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$85.9k 50,000 shares
$1.72
$8.16
Regulus Therapeutics
Regulus Therapeutics RGLS
Chief Financial Officer
Holding Value $3.92M 480,000 shares
Last Trade
Jan 12, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.23M 480,000 shares
$2.57
$8.16
Regulus Therapeutics
Regulus Therapeutics RGLS
Chief Financial Officer
Holding Value $1.22M 150,000 shares
Last Trade
Feb 04, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.39M 150,000 shares
$15.90
$8.16
Regulus Therapeutics
Regulus Therapeutics RGLS
Chief Financial Officer
Holding Value $1.22M 150,000 shares
Last Trade
Jan 22, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.97M 150,000 shares
$13.10
$8.16
Regulus Therapeutics
Regulus Therapeutics RGLS
Chief Financial Officer
Holding Value $1.71M 210,000 shares
Last Trade
Oct 10, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.35M 210,000 shares
$6.44
$8.16
Regulus Therapeutics
Regulus Therapeutics RGLS
Chief Financial Officer
Holding Value $816k 100,000 shares
Last Trade
Aug 30, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$625k 100,000 shares
$6.25
$8.16

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up